: iStockAnalyst.com Symbols Feed

25 Option Write Ideas For October Expiration Friday

Fri, 16 Oct 2009 13:49:27 GMT

In a previous OptionMaestro.com post, I outlined 25 stocks which I wouldn't mind going long at these levels. I wrote about getting long the stocks by using the buy-write option strategy. This is an updated post to that one, adjusting the strikes and prices accordingly for options expiration today.[More...]

Wall Street Ends Higher On Oil, Microsoft (NASDAQ: MSFT) Rallies

Thu, 15 Oct 2009 21:54:28 GMT

US stocks finished up on Thursday as a rally in energy stocks offset a decline in bank shares.[More...]

5 Smart Management Decisions

Thu, 15 Oct 2009 14:30:12 GMT

There's no question that executives have had their hands full navigating the rocky economic environment of the past year. Although we at Morningstar prefer a quality business over topnotch management--as it is much easier for a company to change management teams than industries--recent events have brought home the point that management decisions can have a dramatic effect on a company's fate.[More...]

US Stock Futures Retreat After Goldman Sachs Earnings, Citigroup (NYSE: C) Eyed

Thu, 15 Oct 2009 12:59:28 GMT

US stock futures declined on Thursday after Citigroup and Goldman Sachs Group reported third-quarter results.[More...]

Tickers For The Latest Portfolio Reshaping

Fri, 04 Sep 2009 15:45:21 GMT

Fortunately my portfolio management methods don’t revolve around frequent trading. One of my kids came up to me recently and said, “What did you do today, Dad?” I said, “I made one trade, and I did a bunch of research.” He then asked, “How often do you trade?” I answered, “That was my first trade in a week, and I haven’t traded much in the last two months, but that’s not normal. There is no normal for me. When the market is really volatile, I trade a lot more, selling when stocks are rising, and buying when they are selling off. When the market is relatively placid, I don’t do much.” He looked at me, kind of smiled, and moved on. Information overload from Dad. Most people and investment managers trade too often. They sell their winners too rapidly, and panic too soon on their losers. Now, I’m not advocating “buy and forget,” or Buffett’s statement, “Our favorite holding period is forever.”[More...]

CSL Ltd. (ASX:CSL): First To Begin Swine Flu Vaccine Trial

Wed, 22 Jul 2009 17:28:36 GMT

CSL Limited (ASX:CSL) (PINK:CMXHY) is expected to begin the first human trials for a swine influenza (flu) vaccine on 7/22/09 in Australia. The seven-week trial will inject healthy volunteers age 18-64 as deaths, infections, and media coverage of the H1N1 virus gain momentum across the globe. The seven-week study will be closely monitored to measure the immune responses of the subjects in order to determine the optimal antigen (the substance which elicits an immune response and thus protection f (...)[More...]

Midnight Trader's Pre Market Report for July 16, 2009

Thu, 16 Jul 2009 13:25:00 GMT

Technology shares are lower in the pre-market session. Nokia (NOK) Q2 sales fell to 9.9 bln euros from 13.1 bln euros. EPS fell to 0.15 euros from 0.37 euros. Nokia said its mobile device volumes were 103.2 million units, down 15% year on year and up 11%[More...]

Trends Shaping the Health Care Industry: Part 3

Mon, 08 Jun 2009 12:11:02 GMT

If you have not read the first and second parts of this article, please follow the prior links. By now, you should be getting a quick glimpse of the trends that are influencing health care companies operations and decisions. In my first article I discussed how the government’s and FDA’s agendas are affecting the health care industry, and in my second article, I examined recent M&A activity, generic competition, and trends within the CRO industry. In this article, I will touch over the things that are plaguing Managed Care Organizations (MCO) and Medical Supplies companies and forces that are inspiring growth in Health Care IT.[More...]

Swine Flu Pandemic Threatens Global Economic Recovery

Tue, 28 Apr 2009 11:51:12 GMT

The delicate state of the global economy could be rocked by an outbreak of swine flu, which has killed over 100 people in Mexico and infected many others in the United States, Canada, Spain and New Zealand.[More...]

More Profit Reports Beating Expectations

Thu, 16 Apr 2009 16:05:44 GMT

There were a handful of positive earnings reports this morning, beating consensus expectations. But after yesterday's strong late-day rally, the news isn't propping up the market in early trading. Of course, given the late day turnarounds we have been seeing, its safe to say its still early. (I think the last time I said that the market got whacked) Here are some of the companies that topped earnings estimates: JPMorgan (JPM), Baxter (BAX), Illinois Tool Works (ITW), and Nokia ([More...]

Baxter's Earnings Jump 12 Percent on Strong Bioscience Sales

Fri, 16 Oct 2009 16:48:00 GMT

Oct. 16--Baxter International Inc. reported Thursday that third-quarter profit rose 12 percent, thanks to sales of bioscience products such as its blood-clotting drug Advate.
The Deerfield-based medical-product giant said net income grew to $530 million, or 87 cents a share, compared with $472 million, or 74 cents, in the year-earlier quarter.
Excluding special items, Baxter recorded earnings of 98 cents per share, above its guidance for the quarter.

: iStockAnalyst.com Symbols Feed

25 Option Write Ideas For October Expiration Friday

Wall Street Ends Higher On Oil, Microsoft (NASDAQ: MSFT) Rallies

5 Smart Management Decisions

US Stock Futures Retreat After Goldman Sachs Earnings, Citigroup (NYSE: C) Eyed

Tickers For The Latest Portfolio Reshaping

CSL Ltd. (ASX:CSL): First To Begin Swine Flu Vaccine Trial

Midnight Trader's Pre Market Report for July 16, 2009

Trends Shaping the Health Care Industry: Part 3

Swine Flu Pandemic Threatens Global Economic Recovery

More Profit Reports Beating Expectations

Baxter's Earnings Jump 12 Percent on Strong Bioscience Sales

Baxter Adjusted Profit Tops Estimates, but Currency Exchange Hits Sales; Company Lifts Outlook

Baxter International 3Q profit rises 12 percent

Baxter International 3Q profit rises 12 percent

Skin hydration product unveiled by Baxter

Talecris Biotherapeutics delayed IPO set to debut

Cook Fears Taxes Will Hurt Industry

Wilkowski, Bell Cruise to Easy Wins

Stocks Finish Higher

Baxter 2Q profit rises 8 percent on margins

Baxter Reports Double-Digit EPS Growth for Third Quarter 2009

Baxter Named to Dow Jones Sustainability Index for 11th Consecutive Year

Laureate Pharma Elects New Board Member ; - Joel A. Tune Enhances Organization, Providing Leadership and Strategic Direction -

StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals

StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.

Baxter Completes Production of First Commercial Batches of A/H1N1 Pandemic Vaccine

Baxter Declares Quarterly Dividend and Announces New Share Repurchase Authorization

Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook

Baxter and Halozyme Announce Completion of Patient Enrollment in Phase III Pivotal Trial of GAMMAGARD LIQUID™ with rHuPH20 Enzyme

Baxter and Flamel Technologies Announce Collaboration to Formulate Longer Acting Forms of Blood Clotting Factors

Form 4 BAXTER INTERNATIONAL For: Oct 21 Filed by: GAVIN JAMES R III (10K)

Form 3/A Scharf David P. For: Sep 01 (10K)

Form 3 Scharf David P. For: Sep 01 (10K)

Form 4 GAVIN JAMES R III For: Jul 16 (10K)

Form 4 Terrell Karenann K For: May 11 (10K)

Form 4 Baughman Michael J For: May 11 (10K)

Form 4 GATLING JAMES M For: May 11 (10K)

Form 4 STALLKAMP THOMAS T For: May 05 (10K)

Form 4 BAXTER INTERNATIONAL For: May 05 Filed by: STROUCKEN ALBERT P L (10K)

Form 4 BAXTER INTERNATIONAL For: May 05 Filed by: STORM KEES J (10K)